These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3208301)

  • 1. [Monitoring adverse drug effects in Czechoslovakia].
    Fousková H
    Cesk Farm; 1988 Oct; 37(8):344-5. PubMed ID: 3208301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Classification and profile of adverse drug effects].
    Cordonnier M
    Bull Soc Belge Ophtalmol; 2007; (304):15-6. PubMed ID: 17718223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular adverse drug reactions and the National Registry of Drug-Induced Ocular Side Effects.
    Fraunfelder FW
    Insight; 2004; 29(2):7-11. PubMed ID: 15709350
    [No Abstract]   [Full Text] [Related]  

  • 4. [The determination and evaluation of adverse effects of drugs].
    Uhlír O
    Cas Lek Cesk; 1967 Apr; 106(15):392-3. PubMed ID: 6047296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Status of side effects. 3. Intensified registration of adverse effects. What should be reported?].
    Myhr K; Lunde PK
    Tidsskr Nor Laegeforen; 1989 Nov; 109(31):3226-8. PubMed ID: 2595689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reports of adverse effects in 1987: reduction since last year].
    Lakartidningen; 1988 May; 85(21):1906-8. PubMed ID: 3379993
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 8. [Registration of adverse effects and complications].
    Asdahl T
    Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2114-5. PubMed ID: 5479234
    [No Abstract]   [Full Text] [Related]  

  • 9. European system for reporting of adverse reactions and drug defects--second report 1982-1983.
    Nuklearmedizin; 1984 Apr; 23(2):107-8. PubMed ID: 6473112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse effects of drugs and computerized registries--a threat or a possibility?].
    Bergman U; Linnarsson R; Boethius G; Matell G; Keisu M; Peterson H; Kalles I; Wiholm BE; Krakau I; Westerholm B
    Lakartidningen; 1989 Apr; 86(16):1506-8. PubMed ID: 2725139
    [No Abstract]   [Full Text] [Related]  

  • 11. The system for "reporting of adverse reactions and drug defects" (1980-1982)--first report.
    Nuklearmedizin; 1982 Dec; 21(6):274-7. PubMed ID: 7167391
    [No Abstract]   [Full Text] [Related]  

  • 12. [The registration of drug side effects].
    Fiedler H
    Dtsch Med Wochenschr; 1990 Aug; 115(34):1294. PubMed ID: 2390944
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacoepidemiology].
    Hallas J; Sørensen HT
    Ugeskr Laeger; 2005 May; 167(20):2186-90. PubMed ID: 15987081
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monitoring adverse drug effects in Spain].
    Laporte JR
    Therapie; 1987; 42(1):63-4. PubMed ID: 3590069
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
    Lagier G; Vincens M; Lefebure B; Frelon JH
    Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
    [No Abstract]   [Full Text] [Related]  

  • 16. New Zealand Committee on adverse drug reactions: sixteenth annual report 1981.
    McQueen EG
    N Z Med J; 1982 Apr; 95(705):230-3. PubMed ID: 6953361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risks in the delivery of drugs from the point of manufacture to the patient. I. Risks in manufacturing and compounding].
    Samková M; Solich J
    Cesk Farm; 1981 Dec; 30(10):349-54. PubMed ID: 7332939
    [No Abstract]   [Full Text] [Related]  

  • 18. [Establishment of the Bureau side effects animal drugs].
    Kamphuis A
    Tijdschr Diergeneeskd; 1994 Dec; 119(24):765. PubMed ID: 7801311
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy exposure registries: academic opportunities and industry responsibility.
    Wyszynski DF
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):93-101. PubMed ID: 19107953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Welsh Adverse Drug Reactions Scheme: experience of a UK regional monitoring centre.
    Houghton JE; Pinto Pereira LM; Woods FJ; Richens A; Routledge PA
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):93-107. PubMed ID: 8836315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.